troglitazone has been researched along with deoxycytidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, S; Hao, J; Huang, C; Li, X; Liu, J; Liu, W; Ma, Y; Wang, H; Wang, X; Wang, Z; Wu, L; Yang, S; Yu, X; Zhao, T | 1 |
1 other study(ies) available for troglitazone and deoxycytidine
Article | Year |
---|---|
CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms.
Topics: 5'-Nucleotidase; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Endoplasmic Reticulum; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Troglitazone; Xenograft Model Antitumor Assays | 2021 |